Aims: The clinical significance of radial scar (RS)/complex sclerosing lesion (CSL) with high-risk lesions (epithelial atypia) diagnosed on needle core biopsy is not well defined. We aimed at assessing the upgrade rate to ductal carcinoma in situ (DCIS) and invasive carcinoma on the surgical excision specimen in a large cohort with RS/CSL associated with atypia.
Methods: 157 women with a needle core biopsy diagnosis of a RS/CSL with atypia and follow-up histology were studied.
Aim: This survey investigated the variation in the use of the breast core biopsy categories B1 normal and B2 benign.
Method: A survey with case scenarios was circulated to 701 breast pathologists in the UK.
Results: The response rate was 40%.
Breast needle core biopsy (NCB) is now a standard diagnostic procedure in the triple assessment of screen detected breast lesions. Therefore, it is important to provide robust and up-to-date data on the performance of NCB in the screening setting. However, previous studies of NCB have suffered from either limitation in the number of assessed cases or included a mix of symptomatic and screen detected breast lesions.
View Article and Find Full Text PDF